ãªãžã¥ã©ã³æé«æè¡ã®ã¹ããŒãšã€ãžã³ã°äžèœçŸå®¹æ¶²ïŒ é«çŽæã®ããéè²ã®ããã«âŠïŒäœ¿ç𿹿³ãã¡ãã£ãšå€ãã£ãŠããŠçœãæã®éšåãåŒãäžããŠãã®åŸèãéããŠâŠãšæ³šå°åšã¿ãããªäœ¿ãæ¹ð¡ ãšãã¿ã®ããæ¿å¯ãã¯ã¹ãã£ãŒã§èã«éŠŽæããšãã£ã¡ããã£ãšãðð
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬193äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬106äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬12äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬14äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
SK-II ãžã§ãããã£ã¯ã¹ ãªãŒã© ãšãã»ã³ã¹ | 20,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬34äœ | ã·ãäºé²ã ãã§ãªãããã€ãäžããŠãããããã¡ãæŽããŠããã广ãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬193äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬44äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬115äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬82äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
ESTEE LAUDER ã¢ããã³ã¹ ãã€ã ãªã㢠SMR ã³ã³ãã¬ãã¯ã¹ | 12,100å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬70äœ | ããªãã§ããããªã¹ã¹ã¡ã®çŸå®¹æ¶²ã§ãâš | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬32äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬20äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã |
ãœãð£ããã®äººæ°ã¯ãã³ã
ïŒinïŒã®ãšã€ãžã³ã°ã±ã¢UV乳液 åç²§æ°ŽãçŸå®¹æ¶²ã乳液ãã¯ãªãŒã ã UVã«ãããã©ã€ãã¡ã€ã¯ã® 6ã€ã®æ©èœããããªãŒã«ã€ã³ã¯ã³âš SPF43 PA+++ çŸå®¹æ¶²æå80% 也ç¥ã«ããå°ãããç®ç«ããªããã å ãåå°ããèè²ãããŒã³ã¢ããããªãã ã»ãããç·ãå°ãããç®ç«ã¡ã«ãããã ãªã³ã¯ã«ãªãã¬ãã广 䌞ã³ãè¯ã乳液ã§ãä¿æ¹¿åããããŸãã ããŠããŒããã¡ã³ããŒã·ã§ã³ãéããã« 1ã€ã§ä»äžããã®ããªã¹ã¹ã¡ã¿ããã§ãã è¿æã«è»œããåºæããããšããªã©ã« ãã£ãšå¡ã£ãŠUVã±ã¢ã§ããã®ãå¬ããã§ã(*ÂŽâïœ*)
ãã£ãšèŠã271
31
- 2021.11.08
N.ã®äºäžä»£ç®ãã¢ãªã€ã«N.ãããŠãšããæãåºãããæ¹ã«ãªã¹ã¹ã¡âšã¯ããšã®éŠæ°Žã®ãããªéŠããªã®ã§ã¯ããšå¥œããªæ¹ã«ãâ¡äœ¿ãæ¹ã¯ãã³ã°ãã¢ã§1åçã100åçãããã®éããšãã髪ã«éŠŽæãŸãã¹ã¿ã€ãªã³ã°ããŸãã(åç3æç®ã«äœ¿ãéã®ç®å®ãããŸã)å...
ãã£ãšèŠã212
29
- 2020.01.11
ãã¹ãã³ã¹ã¡ã§ç޹ä»ããããã£ã¹ãã¬ãŒãžã£ã¹ãã³ã®äžåãªéŠãã§äžäººåãããéŠãã ãšæããŸãðââïžäœæ¬ãªããŒããããããããªãããããªããŒãããŠããŸãïŒç§ã¯ãã€ãæéŠãšé«ªã®æ¯ã«ã€ããŠãåãããšãã«ãµãã£ãšéŠãããã«ããŠããŸãâ¡ÌâïžéŠæ°ŽããéŠã...
ãã£ãšèŠã184
3
- 2019.12.04
çŸå®¹æ¶²æå85%é åïŒ äœã¯ãã¡ããã åŒ±é žæ§åŠæ¹ã§VIOã«ã䜿ããã®ãå¬ããïŒ ããªã€ãããã¿ã®åå ã«ãªãæ±ãç®èã å€ãè§è³ªãåªããèœãšããŠãããŸãã æ©æŠã¬ã¹ã§æ°æã¡è¯ãæŽãå¿å°ã§ãã ãå®¶ã§ããšã¹ãæ°åãå³ãããŸãïŒ ãã¬ãã·ã¥ããŒãºã®è¯ãéŠãã§ çãããŸãã(*ÂŽâïœ*)
ãã£ãšèŠã175
16
- 2023.02.14
ãšãªã¯ã·ãŒã«ã®ãšã€ãžã³ã°ã±ã¢ãã§ããåç²§æ°Žãã£ãšãã¿ã€ãã䜿ã£ãŠããŸãããšãã¿ããããã¯ã¹ãã£ãŒã§ä¿æ¹¿åãé«ãåç²§æ°Žã§ãðââïžããªããªãããèèããããªãã®ã§ç¶ç¶ããŠäœ¿ã£ãŠããŸã(*ÂŽâïœ*)以å玹ä»ãããã·ã«ã³ããã®ããããã³ããã³ãšçžæ§...
ãã£ãšèŠã173
0
- 2020.01.22
ïŒ8.9ç§ã«äžæ¬å£²ããŠããïŒè³çå ã®äººæ°ã®çŸå®¹æ¶²åç²§æ°Žã®ããš2ããã·ã¥åºããŠéŠŽæãŸããŸãããšãã¿ããããã¯ã¹ãã£ãŒã§ãã€ãããšèãåžãä»ãããã«ãã£ã¡ã(*ÂŽâïœ*)èãžã®æµžéãæ©ãã®ã§ãæéããªãæã«ã䜿ããããã§ãðââïžåãã¯ããããªã...
ãã£ãšèŠã170
0
- 2019.12.17
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
- æå
- ïŒ30mlïŒ æ°ŽãPEG-6ãã°ãªã»ãªã³ãã»ã€ãšãŠã€ãã€ããŽèãšãã¹ãBGãDPGããã€ã¢ã·ã³ã¢ããã1,2-ãããµã³ãžãªãŒã«ãã¢ããšãã©æ¶²æ±ãããŠãã³ã»ã³ã«è±ãšãã¹ãã«ã³ãŸãŠæ ¹ãšãã¹ãã¯ããã°ã¯æå®ãšãã¹ãããŒããã·ã¥ãã«ãŒããªãŒæå®ãšãã¹ãã«ã«ãããŒãã¹ã¯ã¯ã©ã³ãå æ°Žåè§£DNAãããµã³ã¿ã³ã¬ã ãæ°Žæ·»ã¬ã·ãã³ãã«ããªãªã«ã°ãªã³ãŒã«ããã¢ã«ãã³é žNaããšãã«ããã·ã«ã°ãªã»ãªã³ãããã·ã¬ã³ã°ãªã³ãŒã«ãããªãœã«ããŒã20ãã»ã©ããNPãã¢ããã·ã³ããã¬ãããŒã¹ãå°¿çŽ ããã³ãã¬ã³ã°ãªã³ãŒã«ãã¢ã«ããã³ãããµãããŒã«ãé ¢é žãã³ãã§ããŒã«ãã³ã¬ã¹ãããŒã«ãã»ãªã³ããªã¬ã€ã³é žãã©ãŠãªã«ã«ã«ããã³é žã€ããªã³ãã¢ã«ã®ã³é žNaããªã³é ž2Naãããªã¢ã¯ãªã«é žã°ãªã»ãªã«ããã«ã©ã³ããªã³é žK